MGNet is a member of the Rare Disease Clinical Research Network Consortium supported by U54 NS115054

March 2022

MGNet Newsletter 

Consortium Updates

Latest News

NEW   MGNet Announces 2022 MGNet Scholar 

We would like to extend our appreciation to all who applied for the 2022 MGNet Scholar Award Program and want to recognize  Gianvito Masi , MD , at Yale School of Medicine and for being the 2022 MGNet Scholar Awardee!

Gianvito Masi, MD, is an early-career neurologist who completed his residency program at Agostino Gemelli University Polyclinic Hospital, Rome, Italy. From the beginning of his residency, Dr. Masi combined clinical training with laboratory-based research in the field of autoimmune neurology. He developed a special focus on myasthenia gravis (MG), paraneoplastic neurological syndromes, and other autoantibody-mediated neurological diseases. He acquired competence in the diagnosis and treatment of patients with MG and gained significant experience in clinical trials. 

Dr. Masi’s project addresses the crucial gap in our understanding of the immunological characteristics of MG triggered by immune checkpoint inhibitors.